Inventor
SCHALL THOMAS J
US36 patents
⚠️ This page may combine multiple inventors who share the name “SCHALL THOMAS J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CHEMOCENTRYX INC
25 patentsUS7262204B2Aug 28, 2007
Modulation of CCR4 function
CHEMOCENTRYX INC87 citations96
US6559160B1May 6, 2003
Compounds and methods for modulating cxcr3 function
CHEMOCENTRYX INC73 citations95
US6699677B1Mar 2, 2004
Tethered ligands and methods of use
CHEMOCENTRYX INC31 citations91
US6998239B1Feb 14, 2006
Method for identifying a modulator of the binding of CCX CKR polypeptide to a chemokine
CHEMOCENTRYX INC12 citations83
US11304952B2Apr 19, 2022
Combination therapy using a chemokine receptor 2 (CCR2) antagonist and a PD-1/PD-L1 inhibitor
CHEMOCENTRYX INC11 citations82
US11382915B2Jul 12, 2022
Treatment of focal segmental glomerulosclerosis with CCR2 antagonists
CHEMOCENTRYX INC2 citations73
US10758540B2Sep 1, 2020
Treatment of focal segmental glomerulosclerosis with CCR2 antagonists
CHEMOCENTRYX INC4 citations73
US6835547B1Dec 28, 2004
Methods for identifying modulators of CCX CKR activity
CHEMOCENTRYX INC7 citations71
US10568870B2Feb 25, 2020
Reducing tumor burden by administering CCR1 antagonists in combination with PD-1 inhibitors or PD-L1 inhibitors
CHEMOCENTRYX INC2 citations69
US7253007B2Aug 7, 2007
Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
CHEMOCENTRYX INC5 citations69
US7025968B2Apr 11, 2006
CMV vaccines
CHEMOCENTRYX INC7 citations69
US6740324B2May 25, 2004
Methods and compositions useful for stimulating an immune response
CHEMOCENTRYX INC10 citations69
US6992084B2Jan 31, 2006
Compounds and methods for modulating CXCR3 function
CHEMOCENTRYX INC3 citations62
US11844790B2Dec 19, 2023
Methods of treating hidradenitis suppurativa
CHEMOCENTRYX INC0 citations60
US6821998B2Nov 23, 2004
Arylamines as inhibitors of chemokine binding to US28
CHEMOCENTRYX INC2 citations60
US11744822B2Sep 5, 2023
Reducing tumor burden by administering CCR1 antagonists in combination with PD-1 inhibitors or PD-L1 inhibitors
CHEMOCENTRYX INC0 citations59
US7442512B2Oct 28, 2008
Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
CHEMOCENTRYX INC5 citations59
US7572600B2Aug 11, 2009
Enzymatic activities in chemokine-mediated inflammation
CHEMOCENTRYX INC3 citations57
US7108990B2Sep 19, 2006
Chemokine receptor
CHEMOCENTRYX INC0 citations51
US7101894B2Sep 5, 2006
Bicyclic compounds as inhibitors of chemokine binding to US28
CHEMOCENTRYX INC0 citations49
US7871619B2Jan 18, 2011
Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
CHEMOCENTRYX INC1 citations48
US7777009B2Aug 17, 2010
Compositions for detecting and treating diseases and conditions related to chemokine receptors
CHEMOCENTRYX INC0 citations48
US7413866B2Aug 19, 2008
Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
CHEMOCENTRYX INC0 citations48
US7361329B2Apr 22, 2008
Compositions for inducing an immune response
CHEMOCENTRYX INC0 citations45
USRE39849ESep 18, 2007
Methods for identifying modulators of CCX CKR activity
CHEMOCENTRYX INC0 citations41
SCHERING CORP
10 patentsUS6512103B1Jan 28, 2003
Mammalian chemokine reagents
SCHERING CORP32 citations91
US6548654B1Apr 15, 2003
DNA encoding mammalian CX3C chemokine genes
SCHERING CORP13 citations83
US7279460B2Oct 9, 2007
Chemokine TECK polypeptides
SCHERING CORP7 citations73
US6723520B2Apr 20, 2004
Antibodies that bind chemokine teck
SCHERING CORP11 citations73
US7585502B2Sep 8, 2009
Mammalian CX3C chemokine antibodies
SCHERING CORP4 citations72
US6566503B2May 20, 2003
Mammalian CX3C chemokine
SCHERING CORP11 citations71
US7276238B2Oct 2, 2007
Methods for using chemokine teck
SCHERING CORP2 citations62
US7785804B2Aug 31, 2010
Mammalian CX3C chemokine antibodies
SCHERING CORP2 citations61
US8343492B2Jan 1, 2013
Method for blocking binding of CX3C chemokines using CX3C chemokine antibodies
SCHERING CORP0 citations51
US7132508B2Nov 7, 2006
Mammalian chemokine reagents
SCHERING CORP0 citations51